Organisms | Susceptibility | |||||||
---|---|---|---|---|---|---|---|---|
Ampicillin + Gentamicin (A) | Ampicillin + Cefotaxime (B) | Cloxacillin + Gentamicin (C) | Regimen coverage | |||||
Number of isolates | Number Tested (%) | Number susceptible (%) | Number Tested (%) | Number susceptible (%) | Number Tested (%) | Number susceptible (%) | ||
Gram negatives | 109 | 101 (92.6) | 38 (37.6)a | 68 (62.4) | 32 (47.1)a | 75 (68.8) | 52 (69.3)b | C > B = A; p = 0.001 |
Enterobacteriacea | 79 | 74 (93.7) | 24 (32.4) | 55 (69.6) | 27 (49.1) | 53 (67.1) | 37 (69.8) | |
Acinetobacter species | 16 | 16 (100) | 10 (62.5) | 13 (81.2) | 5 (38.4) | 13 (81.2) | 8 (61.5) | |
Pseudomonas species | 11 | 11 (100) | 4 (36.4) | - | - | 9 (81.8) | 7 (77.7) | |
Others | 3 | |||||||
Gram positives | 610 | 511 (83.8) | 159 (31.1)b | 356 (58.4) | 56 (15.7)a | 211 (34.6) | 153 (72.5)b | C > A > B; p = 0.001 |
Enterococcus species | 43 | 37 (86.1) | 8 (21.6) | 37 (86.1) | 7 (18.9) | - | - | |
Staphylococcus aureus | 76 | 67 (88.2) | 34 (50.7) | 59 (77.6) | 5 (8.5) | 69 (90.7) | 46 (66.7) | |
CoNS | 431 | 376 (87.2) | 107 (28.5) | 226 (52.4) | 26 (11.5) | 111 (25.7) | 93 (83.7) | C > A > B; p = 0.001 |
Streptococcus species | 59 | 31 (52.5) | 10 (32.3) | 34 (57.6) | 18 (30.5) | 31 (52.5) | 14 (45.2) | |
Others | 1 | |||||||
Total | 719 | 612 (85.1) | a197 (32.2)b | 424 (58.9) | a 88 (20.7) a | 286 (40.0) | a205 (71.7)c | C > A > B; p = 0.001 |
Total excluding CoNS | 288 | 236 (81.9) | a90 (38.1)a | 198 (68.8) | b 62 (31.3)a | 175 (60.7) | a112 (64.0)b | C > B = A; p = 0.001 |
Polymicrobial infections | 20 | 19 (95.0) | 4 (21)a | 18 (90.0) | 2 (11.1)a | 20 (100.0) | 5 (25.0)a | C = B = A; p = 0.540 |
2 organisms | 17 | 16 (94.1) | 1 (6.3) | 15 (88.2) | 1 (6.7) | 17 (100) | 4 (23.5) | |
3 organisms | 3 | 3 (100) | 3 (100) | 3 (100) | 1 (33.3) | 3 (100) | 1 (33.3) |